Nurix
Michael Hagan is a Senior Clinical Trial Manager at Nurix Therapeutics since June 2021, with extensive experience in managing US study operations for various Phase II, III, and EAP clinical trials in multiple therapeutic areas. Previous roles include Senior Clinical Trial Manager and Senior Clinical Research Associate at Precision Oncology, and Senior Clinical Research Associate at Medpace, where responsibilities included feasibility assessments, site selection, and compliance with ICH/GCP guidelines. Earlier experience as a Country Lead Monitor at Bayer HealthCare involved overseeing clinical trial conduct, managing CRA teams, and developing training materials. Michael Hagan began a career in clinical research as a Clinical Research Associate at Novartis. Academic qualifications include a Bachelor of Science in Sociology from the University of Michigan.
This person is not in any offices
Nurix
3 followers
Nurix Therapeutics discovers drugs that harness the body's natural process to control protein levels. Nurix is focused on developing drugs to treat cancer including the novel, small molecule immuno-oncology agents.